Back to search

Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.

Data up to Jan 2025

Published1995
Citations229
References35
Clinical Trials (1)

Total Citations Per Year

Abstract

References (35)

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1987 • 64,270 citations

The Steroid and Thyroid Hormone Receptor Superfamily

1988 • 7,590 citations

LNCaP model of human prostatic carcinoma.

1983 • 1,749 citations

Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

1979 • 1,595 citations

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

1992 • 1,514 citations

Cancer statistics, 1994

1994 • 1,345 citations

Isolation of a human prostate carcinoma cell line (DU 145)

1978 • 1,176 citations

Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation

1992 • 657 citations

Newly Identified Actions of the Vitamin D Endocrine System*

1992 • 563 citations

The LNCaP cell line--a new model for studies on human prostatic carcinoma.

1980 • 531 citations

Molecular Cloning of Complementary DNA Encoding the Avian Receptor for Vitamin D

1987 • 516 citations

Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

1990 • 514 citations

Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

1994 • 489 citations

Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.

1993 • 475 citations

Vitamin D and prostate cancer: a prediagnostic study with stored sera.

1993 • 357 citations

The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 1 alpha,25-dihydroxyvitamin D3.

1992 • 226 citations

CLINICAL COUNTERPOINT: Vitamin D: New Actions, New Analogs, New Therapeutic Potential*

1992 • 223 citations

Ligand Modulates the Conversion of DNA-Bound Vitamin D3 Receptor (VDR) Homodimers into VDR-Retinoid X Receptor Heterodimers

1994 • 182 citations

1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.

1993 • 172 citations

Establishment of a New Prostatic Carcinoma Cell Line (TSU-PR1)

1987 • 149 citations

Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA.

1993 • 144 citations

Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture.

1982 • 136 citations

Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3.

1994 • 127 citations

Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases.

1993 • 113 citations

Monoclonal antibodies to chick intestinal receptors for 1,25-dihydroxyvitamin D3. Interaction and effects of binding on receptor function.

1984 • 91 citations

Avian and mammalian receptors for 1,25-dihydroxyvitamin D3: in vitro translation to characterize size and hormone-dependent regulation.

1987 • 85 citations

Identification of a vitamin D responsive element in the promoter of the rat cytochrome P45024gene

1994 • 65 citations

Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma

1989 • 62 citations

Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growth

1993 • 60 citations

A serum‐free defined medium capable of supporting growth of four established human prostatic carcinoma cell lines

1994 • 47 citations

Chromosome identity of human prostate cancer cell lines, PC-3 and PPC-1

1993 • 44 citations

The Relationship between the Vitamin D System and Cancer

1986 • 35 citations

Formation of 19-nor-10-keto-25-hydroxyvitamin D3 in cultured mammalian cells

1984 • 31 citations

25-Hydroxyvitamin D-24-Hydroxylase in Phytohemagglutinin-Stimulated Lymphocytes: Intermediate Bioresponse to 1,25-Dihydroxyvitamin D3of Cells from Parents of Patients with Vitamin DDependent Rickets type II*

1990 • 22 citations

Specific Receptors for Vitamin D3 in Human Prostatic Carcinoma Cells

1991 • 8 citations

Cited By (0)

Loading...
Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by… (1995) – PubMed | Metascience Observatory Explorer